Galapagos aims to sell services division to fuel internal R&D pipeline
By Nuala Moran
Friday, March 7, 2014
LONDON – Galapagos NV is putting its drug discovery services arm on the market to provide funding for the clinical development of its internal pipeline.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.